NCT01522248View on ClinicalTrials.gov

Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Influenza Virus Vaccine
Interventions
BIOLOGICAL

Trivalent Inactivated Influenza vaccine

0.5 ml IM once only

Trial Locations (1)

21205

Johns Hopkins Center for Immunization Research, Baltimore

All Listed Sponsors
lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT01522248 - Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study | Biotech Hunter | Biotech Hunter